Trusted News Discovery Since 2008
{{/content}}
Gilead says remdesivir cuts death risk
Video Credit: Reuters Studio
Published on July 10, 2020 - Duration: 01:04s
Gilead says remdesivir cuts death risk
Gilead Sciences said Friday additional data from a late-stage study showed its antiviral remdesivir reduced the risk of death and significantly improved the conditions of severely ill COVID-19 patients.
Fred Katayama reports.
You are here
Related videos from verified sources
Drugmaker Says Remdesivir Can Lower COVID-19 Death Risk By 62% 00:32
Video credit: Wochit Tech - Published on July 14, 2020